Zhu, Wenzhi
Li, Shuxia
Huang, Yan
Wang, Xiaoyi
Tan, Hongyu
Article History
Received: 25 November 2025
Accepted: 8 May 2026
First Online: 9 June 2026
Declarations
:
: This prospective observational study was approved by the Institutional Review Board of Peking University Cancer Hospital(No.2023KT62)and registered in the Chinese Clinical Trial Registry (No.ChiCTR2400086435). Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare no competing interests.